Daniel Ek’s body-scanning startup Neko Health opens first US office, in New York

Nairavoice | Aug 18, 2026 739 0 2 min read
Daniel Ek’s body-scanning startup Neko Health opens first US office, in New York

Neko Health’s promised U.S. expansion arrives on September 24, when the health-scanning startup opens its first American office. It will be located in SoHo, Manhattan’s home of luxury shopping, at 300 Lafayette Street.

Neko was founded by Spotify co-founder and CEO Daniel Ek and Hjalmar Nilsonne, who serves as Neko’s CEO. The company says that more than 25,000 New Yorkers have joined a waitlist.

As we previously reported, Neko Health has developed proprietary body-scanning technology, which it pairs with bloodwork and data from fitness devices to assess a person’s health. Currently, the startup has locations in the U.K. and Sweden. When it raised a $700 million Series C last month, it said that 100,000 people already had scans.

Neko is among a growing number of health-scanning companies created by tech founders or backed by VCs. For instance, Midjourney, the AI lab best known for its AI image and video creation model and website, is also creating a body scanner, which it plans to integrate into a spa experience. It plans to open in San Francisco in 2027. Tony Robbins and Peter Diamandis also have a longevity company called Fountain Life that does scans and health assessments. Function Health, co-founded by well-known wellness podcaster Dr. Mark Hyman, offers blood testing, and it added body scans after acquiring the startup Ezra. Function just took on a $450 million loan from General Catalyst’s Customer Value Fund, where companies repay the money via profit-sharing arrangements.

❤Enjoying this article? Support our work with a small crypto donation.
Show Some Love By Sharing

Discover more from NAIRAVOICE.COM.NG

Subscribe to get the latest posts sent to your email.

❤Enjoyed this? A small crypto donation helps us keep publishing.
Nairavoice
Nairavoice

Contributor at NairaVoice.com.ng

Related Posts

Leave a Reply